The complexity of TNF-related apoptosis-inducing ligand

Annals of the New York Academy of Sciences

Volumn 926, Issue , 2000, Pages 52-63

  Abe, Karon ^a   Kurakin, Alexei ^b   Mohseni Maybodi, Mehrdad ^a   Kay, Brian ^c   Khosravi Far, Roya ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cancer therapy; TNF superfamily; TRAIL

Indexed keywords

FLICE INHIBITORY PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER; CANCER THERAPY; CELL DEATH; CELL TRANSFORMATION; CONFERENCE PAPER; HUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL DESTRUCTION;

EID: 0034508661     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05598.x     Document Type: Conference Paper

References (78)

1. Apoptosis signaling by death receptors
2. Fas ligand-induced apoptosis
3. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
4. Tumor necrosis factor receptor and Fas signaling mechanisms
5. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
6. Apoptosis in the pathogenesis and treatment of disease
7. Apoptosis in tumorigenesis and cancer therapy
8. Molecular targets for drug development
9. Death receptors: Signaling and modulation
10. The TRAIL to selective tumor death
11. Apoptosis control by death and decoy receptors
12. TRAIL: A molecule with multiple receptors and control mechanisms
13. To die or not to die - The quest of the TRAIL receptors
14. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
15. Safety and antitumor activity of recombinant soluble Apo2 ligand
16. Control of apoptosis signaling by Apo2 ligand
17. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA
18. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
19. Identification and characterization of a new member of the TNF family that induces apoptosis
20. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
21. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
22. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation
23. The receptor for the cytotoxic ligand TRAIL
24. Characterization of two receptors for TRAIL
25. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
26. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
27. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
28. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
29. A novel receptor for Apo2L/TRAIL contains a truncated death domain
30. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
31. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
32. A novel domain within the 55 kD TNF receptor signals cell death
33. Apoptosis by death factor
34. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
35. Caspases: Enemies within
36. An essential role for NF-κB in preventing TNF-α-induced cell death
37. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
38. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
39. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
40. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
41. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
42. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
43. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
44. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
45. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
46. Apo2L/TRAIL-dependent recruitment of endogenous FADD and capase-8 to death receptors 4 and 5
47. FADD/MORT1 and capase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
48. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL
49. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
50. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
51. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
52. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
53. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
54. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
55. From peptides to drugs via phage display
56. Phage display
57. Convergent evolution with combinatorial peptides
58. Molecular recognition properties of the C-terminal Sh3 domain of the Cbl associated protein
59. Casper is a FADD- and caspase-related inducer of apoptosis
60. Inhibition of death receptor signals by cellular FLIP
61. CASH, a novel caspase homologue with death effector domains
62. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
63. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death
64. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex
65. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis
66. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD- 95-induced apoptosis
67. Inhibition of fas death signals by FLIPs
68. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
69. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma
70. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
71. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
72. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
73. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP
74. Molecular determinants of response to TRAIL in killing of normal and cancer cells
75. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
76. Activation of NF-kappaB by FADD, Casper, and caspase-8
77. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and erk signaling pathways
78. The role of c-FLIP in modulation of CD95-induced apoptosis